SYDNEY, Australia, March 18, 2019 (GLOBE NEWSWIRE) -- Hudson RPO, along with its client, AstraZeneca Australia have been named Innovative HR Team winner by HRD magazine. The award recognises the most forward-thinking and progressive recruitment teams in Australia and New Zealand.
In 2015, AstraZeneca selected Hudson RPO as its recruitment outsourcing partner to optimise AstraZeneca’s talent acquisition function. By leveraging artificial intelligence, online reference checking tools, and video interviewing, the team hired more than 300 high-potential recruits in sales, marketing, medical, and operations in 2018 while achieving a 50 percent reduction in time-to-fill at a record low cost for the biopharmaceutical organisation.
“The best recruitment strikes a balance of technology plus human touch”, added Kimberley Hubble, Asia Pacific CEO of Hudson RPO. “Technology reduces time spent on administrative tasks so our recruitment consultants can focus on sharing their expertise and providing the best candidate experience possible. I couldn’t be prouder of our team’s ability to leverage both to provide record-breaking results for AstraZeneca”.
“In our competitive industry, it’s crucial that we hire the best talent to meet our changing patient needs and the evolving scientific demands associated with life-saving medications”, said Liz Chatwin, Country President Australia & New Zealand at AstraZeneca. “We must constantly optimise our talent acquisition process to attract the highest quality talent. Combining the most advanced recruitment expertise with the most innovative technology tools is a must for staying one step ahead in the market, and I couldn’t be more pleased with the outcome”.
About Hudson RPO
Hudson Global, Inc. is a leading total talent solutions provider operating under the brand name Hudson RPO. We deliver innovative, customised recruitment outsourcing and total talent solutions to organisations worldwide. Through our consultative approach, we develop tailored talent solutions designed to meet our clients’ strategic growth initiatives. As a trusted advisor, we meet our commitments, deliver quality and value, and always aim to exceed expectations. For more information, please visit us at www.hudsonrpo.com.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information, please visit www.astrazeneca.com and www.astrazeneca.com.au.
Contact: Nicki Freeman
Hudson Global, Inc.
Phone: +61 429 472 822